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The discovery that the human CFH Y402H allele is asso-
ciated with the risk for developing age-related macular degen-
eration (AMD) initiated the modern study of the genetics of 
this disease [1-6]. The CFH gene (Gene ID: 3075, OMIM: 
134370) encodes for complement factor H, one of the regula-
tors of the alternative pathway of the complement activation 
system. This discovery also shed light on the complement 
system and its dysfunction as a possible role for the develop-
ment of AMD. It is now clear that AMD is much like other 
complex genetic diseases in that susceptibility develops as 
a function of age, genetics, and non-genetic influences [7].
The use of the mouse as an animal model has been 
explored as a reasonable alternative to working with human 
specimens for the study of Cfh genetics and phenotypes 
[8-10]. The mouse and human CFH gene clusters are similar 
but not identical. Experimental comparisons at every level of 
detail from the structure of the gene cluster to the physiology 
of the entire complement system have not been fully explored. 
The best clarification of the relative structures of the mouse 
and human CFH gene clusters, at the levels of nucleotide and 
amino acid sequence and the relative homology of CFH and 
its related genes within the two species, can be found in an 
article by Hellwage et al. [11].
Despite high interest in understanding complement 
factor H function in the eye, total agreement has not yet been 
achieved regarding which cells in the outer retina express the 
Cfh message and the nature of the protein distribution. Several 
studies report the expression of Cfh and Cfh-related genes in 
the retina and RPE of the posterior pole in the mouse [12,13]. 
One study found Cfh protein only in Bruch’s membrane of 
the mouse eye [14]. Another study reported Cfh protein in 
the mouse photoreceptor sensory cilium complex [15]. The 
literature referenced outlines only potential problems when 
comparing mouse and human CFH genes. Many investigators 
have explored the distribution of mouse complement factor H 
using antibodies generated against human complement factor 
H as the antigen [13,14,16,17]. In particular, most of the anti-
body reagents used do not have clear references for the host 
organism, the exact identity of the antigen used, and the state 
of antibody purification of the final product. Frequently, the 
term “affinity purified” used in publications may mean only 
an isolated immunoglobulin G (IgG) fraction.
In this work, we reexamined the expression of the Cfh 
gene cluster in the mouse RPE/choroid using a full set of 
quantitative real-time PCR (qPCR) assays for all genes in 
the mouse Cfh cluster. Cells that synthesize Cfh mRNA 
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Purpose: To determine the localization of complement factor H (Cfh) mRNA and its protein in the mouse outer retina.
Methods: Quantitative real-time PCR (qPCR) was used to determine the expression of Cfh and Cfh-related (Cfhr) 
transcripts in the RPE/choroid. In situ hybridization (ISH) was performed using the novel RNAscope 2.0 FFPE assay to 
localize the expression of Cfh mRNA in the mouse outer retina. Immunohistochemistry (IHC) was used to localize Cfh 
protein expression, and western blots were used to characterize CFH antibodies used for IHC.
Results: Cfh and Cfhr2 transcripts were detected in the mouse RPE/choroid using qPCR, while Cfhr1, Cfhr3, and Cfhrc 
(Gm4788) were not detected. ISH showed abundant Cfh mRNA in the RPE of all mouse strains (C57BL/6, BALB/c, 129/
Sv) tested, with the exception of the Cfh−/− eye. Surprisingly, the Cfh protein was detected by immunohistochemistry 
in photoreceptors rather than in RPE cells. The specificity of the CFH antibodies was tested by western blotting. Our 
CFH antibodies recognized purified mouse Cfh protein, serum Cfh protein in wild-type C57BL/6, BALB/c, and 129/Sv, 
and showed an absence of the Cfh protein in the serum of Cfh−/− mice. Greatly reduced Cfh protein immunohistological 
signals in the Cfh−/− eyes also supported the specificity of the Cfh protein distribution results.
Conclusions: Only Cfh and Cfhr2 genes are expressed in the mouse outer retina. Only Cfh mRNA was detected in the 
RPE, but no protein. We hypothesize that the steady-state concentration of Cfh protein is low in the cells due to secretion, 
and therefore is below the detection level for IHC.
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were identified using a novel in situ hybridization (ISH) 
method with probes specifically designed to not cross-react 
with related genes. We also investigated the distribution of 
complement factor H in the outer retina and RPE using two 
antibodies that were raised against mouse-specific protein 
sequences. Finally, we investigated a freeze substitution 
protocol to improve the preservation of structure and antige-
nicity in the outer retina.
METHODS
Animals: Male BALB/c and C57BL/6 mice were purchased 
from the Jackson Laboratory (Bar Harbor, ME). Eyes from 
129/Sv Cfh−/− mice (5 1/2 months of age) and their back-
ground strain 129/Sv (6 months of age) were a gift from 
Dr. R. Radu (Jules Stein Eye Institute, UCLA). Mice were 
provided with water and standard chow (Rodent Diet 5001, 
PMI Feeds, Inc., Shoreview, MN) ad libitum and maintained 
on a 12 h:12 h light-dark cycle. All animals were handled 
and housed according to the ARVO Statement for the Use of 
Animals in Ophthalmic and Vision Research. This research 
was conducted according to protocols approved by the Insti-
tutional Animal Care and Use Committee at the University 
of California, Davis.
RNA isolation and quantitative real-time PCR: Eyes were 
collected, immobilized to a Petri dish using superglue, 
and quickly dissected by a circumferential cut posterior to 
the limbus. The retina was removed and the RPE/choroid 
dissected out and placed in 300 μl of RNAlater (Ambion, Life 
Technologies, Grand Island, NY) within a minute, following 
our previously published rapid dissection procedure [18]. 
Tissue was stored at −20 °C until subsequent processing.
Total RNA from the RPE/choroid tissue samples were 
extracted and purified using the Qiagen RNeasy isolation 
kit (Qiagen, Valencia, CA) following the manufacturer’s 
protocol. The quantity and quality of total RNA from each 
sample was analyzed using the Agilent 2100 BioAnalyzer and 
RNA 6000 Nano Kit (Agilent, Santa Clara, CA).
qPCR experiments were performed using total RNA 
isolated from the RPE/choroid of 2 month old mice with 
biologic replicates of n=6 (3 males and 3 females), for a total 
of six animals. qPCR was also performed on the 129/Sv and 
129/Sv Cfh−/− strains using biologic replicates (n=2 males and 
n=4 females), for a total of six animals. Each biologic repli-
cate was run in triplicate. The reverse transcription of mRNA 
was performed using the QuantiTect Reverse Transcrip-
tion Kit (Qiagen). The following TaqMan assays (Applied 
Biosystems by Life Technologies, or ABI) were performed 
for qPCR: mouse Cfh (ABI No. Mm01299243_m1) [ABI 
part of Life Technologies, Grand Island, NY], mouse Cfhr1 
(ABI No. Mm01295946_m1), mouse Cfhr2 [Cfhrb_4/2 (ABI 
No. Mm03040548_m1)], mouse Gm4788 [Cfhrc (ABI No. 
Mm02581433_mH)], mouse Cfhr3 custom made, and three 
reference genes, B2mex (Mm00437762_m1), Gapdh (ABI No. 
Mm03302249_g1), and Hpr1 (ABI No. Mm01545399_m1).
Tissue processing for immunohistochemistry and in situ 
hybridization: Animals were sacrificed by asphyxiation with 
gaseous CO2 in a closed chamber. For orientation in paraffin, 
the superior region of each eye was marked using tissue dye 
(The Davidson Marking System, Bradley Products Inc., 
Bloomington, MN, catalog #1003–6) before enucleation with 
curved scissors. Eyes were fixed using one of two methods. 
In the first method, the whole globe was immersed in freshly 
prepared 10% neutral buffered formalin overnight after 
enucleation and subsequently used for in situ hybridization. 
Eyes to be used for immunohistochemistry (IHC) were fixed 
using a second fixation method involving freeze substitution. 
Each excised eye was snap frozen in dry ice–cooled liquid 
propane for 30 s, and then transferred to dry ice–cooled 
methanol containing 3% glacial acetic acid. Eyes immersed 
in this fixative were kept at −80 °C for 48 h, followed by over-
night at −20 °C, after which they were embedded in paraffin 
as follows: Eyes were warmed to room temperature and left 
for 1–2 h in 100% ethanol, 2×30 min in 100% ethanol, 2×15 
min in xylene, and 3×40 min in paraffin.
Each eye was placed in a paraffin mold in an orientation-
specific manner. First, the eye was manipulated so that the 
previous corneal marking was in the 12 o’clock position. 
Next, the eye was rotated so that the anterior segment faced 
the right side of the mold before the embedding ring was 
placed on top, thus preserving the orientation of the eye, such 
that when the mold was released from the block, the superior 
orientation was maintained and a sagittal section made of the 
eye when the block was sectioned. Sections were cut using 
a Leica RM2125RT microtome (Leica, Nussloch, Germany) 
at 6 μm. Due to the previous orientation of each eye in the 
paraffin embedding step, a section through the optic disc 
represented a sagittal section.
In situ hybridization: In situ hybridization was performed 
using a mouse Cfh probe (catalog, #403671, Advanced Cell 
Diagnostics [ACD]; Hayward, CA) specific to the Cfh (Acces-
sion #NM_009888.3) sequence region spanning 2131–3109 
bp, and the novel RNAscope 2.0 FFPE Fast Red Assay (ACD) 
as directed by the manufacturer [19] with the following 
modifications: Pretreatment 2 was optimized for each set of 
eyes processed for ISH, the Amp 5 step was reduced to 20 
min, and the hematoxylin staining time was reduced to 2×2 
s. Briefly, paraffin was removed from 6-μm-thick sections 
using xylene, followed by dehydration in 100% ethanol 
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before the slides were dried at room temperature. Endog-
enous peroxidase activity was blocked before the slides were 
boiled in Pretreatment 2, followed by treatment with protease, 
and hybridization with the target oligo probes (ACD). After 
hybridization, a six-step amplification process (preamplifier, 
signal enhancer, amplifier, label probe, signal amp, AP-linked 
labeling) was performed before chromogenic detection 
using Fast Red. Slides were then counterstained with Gill’s 
hematoxylin, dehydrated, and coverslipped using EcoMount 
mounting media (Biocare Medical, Concord, CA). Specific 
ISH signals appeared as punctate red spots. An RPE65 probe 
was used as a positive control, and a bacterial dapB probe was 
used as a negative control.
Antibodies: Goat anti-mouse Cfh and rabbit anti-mouse Cfh 
primary antibodies (Santa Cruz Biotechnology, Santa Cruz, 
CA) were used, along with their appropriate secondary anti-
body (biotinylated bovine anti-goat IgG or cyanine 3 (Cy3) 
conjugated donkey anti-goat IgG; or biotinylated donkey anti-
rabbit IgG) for immunohistochemistry (Jackson ImmunoRe-
search, West Grove, PA). Alkaline phosphatase conjugated 
secondary antibodies (Jackson ImmunoResearch) were used 
for western blots. See Table 1 for a summary of the antibodies 
used.
Western blots: Purified human CFH protein (Complement 
Technology, Inc., Tyler, TX), mouse complement factor H 
(gift from Dr. Claire Harris, Cardiff University), C57BL/6 
mouse serum (1 μl/lane; Bioreclamation LLC, Westbury, 
NY), and mouse serum from 129/Sv and 129/Sv Cfh−/− (1 μl/
lane; gift from Dr. Roxana Radu, Jules Stein Eye Institute, 
UCLA) samples were prepared in sample buffer (Bio-Rad, 
Hercules, CA, catalog #NP0007) with beta mercaptoethanol. 
All samples were electrophoresed on 4–15% Tris-HCl 
gradient gels (Bio-Rad Criterion gels), after which the protein 
bands were transferred onto polyvinylidene fluoride (PVDF; 
Bio-Rad, catalog #162–0174) membranes, and blocked over-
night with 5% nonfat dry milk (EMD Millipore, Billerica, 
MA, catalog #6250) in Tris buffered saline containing 0.05% 
Tween-20 (TBST).
For immunolabeling of western blots, primary antibodies 
were diluted (1 μg/ml) in TBST containing 5% nonfat dry 
milk, incubated 1 h at room temperature, washed in TBST, 
and incubated for 1 h at room temperature in species-specific 
secondary antibodies conjugated to alkaline phosphatase 
(AP) diluted 1:40,000 in TBST. Blots were washed before 
developing in BCIP/NBT substrate (Vector Laboratories, 
Burlingame, CA, catalog #SK-5400). After development, the 
blots were washed in ultrapure water and air dried in the dark.
Immunohistochemistry: Paraffin sections were placed on 
SuperFrost Plus microscope slides and dried overnight at 
room temperature. Sections from freeze-substituted tissue 
were deparaffinized in xylene and hydrated through gradient 
alcohols, washed in PBS (1X; 137 mM NaCl, 2.7 mM KCl, 
Table 1. anTibodies, suppliers, and concenTraTions used for immunohisTochemisTry and wesTern bloTs.
Primary Antibody and Concentration 
Used (Manufacturer & catalog #)
Host 
Species Immunogen
Secondary Antibody (Manufacturer & 
catalog #)
anti-mouse Factor H, affinity purified 
polyclonal, 2 ug/ml (IHC-P), 1 ug/
ml (WB); (Santa Cruz Biotechnology, 
catalog # 17951)
goat Peptide mapping within an 
internal region of Factor H of 
mouse origin (aa 250–300)
Biotinylated bovine anti-goat IgG 
(Jackson ImmunoResearch, catalog # 
805–065–180) Cy3 donkey anti-goat 
IgG (Jackson ImmunoResearch, catalog 
# 705–165–147) Alkaline Phosphatase 
conjugated bovine anti-goat IgG (Jackson 
ImmunoResearch, catalog #805055180)
anti-mouse Factor H, recombinant poly-
clonal, 6 ug/ml (IHC-P), 1 ug/ml (WB), 
(Santa Cruz Biotechnology, catalog # 
33157)
rabbit Amino acids 61–360 mapping 
within an internal region of 
Factor H of mouse origin
Biotinylated donkey anti-rabbit IgG 
(Jackson ImmunoResearch, catalog # 
711–065–152) Alkaline Phosphatase goat 
anti-rabbit IgG (Jackson ImmunoRe-
search, catalog #111055003)
anti-Rhodopsin, clone 4D2, monoclonal 
antibody, 1:500, (Millipore, catalog # 
MABN15)
mouse Rat rod outer segments corre-
sponding to rat Rhodopsin at 
the N-terminus
Cy2 conjugated donkey anti-mouse IgG, 
1:100 (Jackson ImmunoResearch, catalog 
#715–225–150)
anti-Opsin, Blue, polyclonal, 1:500, 
(Millipore catalog # AB5407)
rabbit Recombinant human blue opsin Cy5 conjugated donkey anti-rabbit IgG, 
1:100 (Jackson ImmunoResearch, catalog 
#711–175–152)
anti-Opsin, Red/Green, 1:500, poly-
clonal, (Millipore catalog # AB5405)
rabbit Recombinant human red/green 
opsin
Cy5 conjugated donkey anti-rabbit IgG, 
1:100 (Jackson ImmunoResearch, catalog 
#711–175–152)
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8 mM Na2HPO4, and 2 mM KH2PO4, pH 7.4; Ambion, 
Grand Island, NY, catalog #AM9625), and post fixed in 4% 
paraformaldehyde in PBS, pH 7.4 for 10 min and washed 
again with PBS. Antigen retrieval was performed at 98 °C 
using 1X Dako Target Retrieval Solution (DakoCytomation, 
Carpinteria, CA, catalog #S1699) for 20 min and left at room 
temperature for 20 min before washing with PBS. Finally, 
the slides were blocked using 3% BSA in PBS buffer for 2 h 
at room temperature.
Primary antibody binding was performed overnight at 
4 °C. Antibodies were diluted to a specific concentration 
in their blocking buffer. After primary antibody exposure, 
sections were washed in PBS containing 0.1% Tween-
20, and then incubated with the appropriate biotinylated 
secondary antibody at a concentration of 6 μg/ml diluted in 
PBS containing 0.05% Tween-20 for 30 min, washed, and 
incubated for 30 min in Vectastain ABC-AP reagent (Vector 
Laboratories, catalog #AK-5000). The secondary antibodies 
were evaluated for non-specific labeling using primary 
antibody deletion or an isotype-matched immunoglobulin 
at the same concentration as the primary antibody. Color 
was developed using the BCIP/NBT alkaline phosphatase 
(AP) substrate (Vector Laboratories, catalog #SK-5400). The 
slides were then washed, counter-stained with Nuclear Fast 
Red (Vector Laboratories, catalog #H-3403), washed again, 
dehydrated, cleared in xylene, and coverslipped using Vecta-
Mount permanent mounting media (Vector Laboratories, 
catalog #H-5000).
Immunofluorescent labeling was performed as described 
above until the blocking step. Immunofluorescent blocking 
buffer contained 5% normal donkey serum (Jackson Immu-
noResearch) and 0.3% Triton X-100 (Sigma, St. Louis, MO, 
catalog #T8787) in PBS. After blocking with immunofluo-
rescent blocking buffer, the slides were incubated overnight 
at 4 °C with appropriate primary antibodies diluted in PBS 
containing 0.3% Triton X-100 (Sigma Aldrich, Saint Louis, 
MO). After incubation with primary antibodies, the slides 
were washed with PBS and incubated for 30 min at 37 °C 
with the appropriate f luorescent labeled secondary anti-
bodies diluted in PBS and washed before coverslipping. 
Fluoromount G with 4’,6-diamidino-2-phenylindole (DAPI) 
mounting media (SouthernBiotech, Birmingham, AL, catalog 
#0100–20) was used to coverslip slides.
Double-labeling experiments for Cfh with either fluo-
rescein conjugated wheat germ agglutinin (WGA) or peanut 
agglutinin (PNA; both from Vector Laboratories, catalog 
#FL-1021 and #FL-1071, respectively) were performed using 
eyes from male C57BL/6 mice. Eyes were fixed using the 
freeze substitution method and embedded in paraffin as 
described above. However, these eyes were oriented for 
coronal rather than sagittal sections. The posterior portion 
of the eye was oriented such that it was on the cutting face of 
the paraffin block. Sections from the posterior region of the 
eye were cut at 6 μm and dried overnight at room tempera-
ture. Briefly, double labeling was performed as follows: The 
paraffin was removed in xylene, hydrated through gradient 
alcohols, and washed in PBS. Sections were then post-fixed 
in 4% paraformaldehyde for 10 min before being subjected 
to antigen retrieval at 98 °C for 20 min in 1X Dako Target 
Retrieval Solution (DakoCytomation, catalog #S1699). 
After antigen retrieval, the slides were left at room tempera-
ture for 20 min before washing with PBS containing 0.3% 
Triton X-100. Slides were then blocked for 1 h at 37 °C with 
PBS containing 0.3% Triton X-100 and 5% normal donkey 
serum. The slides were then incubated overnight at 4 °C in a 
humidity chamber with 0.8 μg/ml goat anti-mouse Cfh anti-
body and either 15 μg/ml PNA or 5 μg/ml WGA, both lectins 
conjugated to fluorescein (Vector Laboratories). The next 
morning, the slides were washed with PBS and incubated for 
30 min at 37 °C in a humidity chamber with Cy3 conjugated 
donkey anti-goat IgG (Jackson ImmunoResearch, catalog 
#705–165–147), and coverslipped using Fluoromount G with 
DAPI (SouthernBiotech) mounting media before visualizing 
using an Olympus FluoView FV1000 confocal microscope 
(Olympus America, Inc., Center Valley, PA).
Antibody blocking experiments are used to demonstrate 
specificity in IHC. The lowest goat anti-mouse Cfh antibody 
concentration for IHC was determined and preabsorbed using 
the manufacturer’s protocol and blocking peptide (Santa Cruz 
Biotechnology, catalog #17951 P) for this antibody. Briefly, 
the antibody was combined with a fivefold excess of blocking 
peptide in PBS to a final volume of 500 μl and incubated 
overnight on a rocker at 4 °C. The preabsorbed antibody was 
diluted and used for IHC at the same concentration as the 
non-absorbed antibody (2 μg/ml).
Photography: Slides were viewed and digitized images 
captured using a light microscope (Nikon Eclipse E800; 
Nikon Inc., Melville, NY) and epif luorescence with an 
AF568 filter (Nikon Set 49,005) using QCapture software 
(QImaging, Surrey, Canada).
RESULTS
Structural comparison of human and mouse Cfh gene clus-
ters and proteins: To compare the organization between the 
human and mouse Cfh gene clusters, at the gene and protein 
levels, we used the UC Santa Cruz Gene Browser. The best 
reference in the literature for discussing a comparison of the 
mouse and human CFH gene clusters and associated proteins 
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is the Hellwage et al. paper [11]. The order of genes in the 
human versus the mouse complement clusters is shown 
in Figure 1. The human CFH cluster is located on human 
chromosome 1 within the 360 kb interval located within the 
196-197 Mbp region of Chr1, according to the human genome 
assembly from Feb 2009 (GRCh37/hg19). The cluster is 
located on the “+” strand of chromosome 1, and thus directed 
in the “+” direction. The cluster of mouse Cfh genes is located 
on chromosome 1, within the 670 kb interval located within 
the 140-142 Mbp region of Chr1, according to the UCSC 
Genome Browser, mouse genome assembly from Dec 2011 
(GRCm38/mm10). The cluster is located on the “-” strand of 
chromosome 1 and thus directed in the “-” direction. Note 
that the order of genes in the cluster is different for the mouse 
and human. In the human cluster, the CFH gene is followed 
by CFHR3, CFHR1, CFHR4, CFHR2, and the last one is 
CFHR5. In the mouse cluster, Cfhr2 is located immediately 
downstream of the Cfh gene followed by Gm4788, Cfhr3, 
and Cfhr1. In the human, there is evidence of the expression 
of all six genes mainly in the liver [20]. The simultaneous 
expression of CFH, CFHR3, and CFHR1 has been proposed 
to have functional significance in the pathogenesis of AMD 
[21]. However, no evidence for the expression of the Cfhr3 
and Cfhr1 genes has been found thus far in the mouse eye.
Transcripts for the Cfh gene cluster in the mouse 
were first identified in 1990 [22]. Sixteen years later, two 
transcripts were shown to code for two proteins that were 
expressed [11]. These proteins were termed complement 
factor H-related B (FHR-B) and complement factor H-related 
C (FHR-C). With the full sequencing of the mouse genome, 
it became clear that there are four potential Cfh-related genes 
in the mouse as opposed to five related genes in the human. 
Since various names have historically been used for Cfh and 
Cfh-related genes and their corresponding proteins, we have 
included a table in the Appendix for the synonyms of these 
genes and their proteins (Appendix 1).
The Cfh gene is composed of 20 short consensus repeats 
(SCR) or Sushi domains [11]. SCRs within one gene have vari-
able homologies. When mouse and human CFH sequences 
are compared, the extent of the non-homology of the SCR 
repeats can be easily determined (Figure 2).
Quantification of expression levels of Cfh and Cfhr2 
mRNA in the RPE/choroid with qPCR: To have a quantita-
tive accounting of all possible transcripts from the mouse 
Cfh gene cluster, we performed qPCR analysis on the RNA 
samples derived from the RPE/choroid of the mouse. Primers 
for all Cfh-related genes were not commercially available, 
and as a result, we had ABI develop a custom qPCR TaqMan 
assay for mouse Cfhr3. The qPCR studies were performed 
using qPCR TaqMan assays (ABI) for all mouse Cfh and 
Cfhr genes that were designed to not cross-react with other 
members of the family.
qPCR was performed on the RPE/choroid from male 
(n=3) and female (n=3) C57BL/6 mice at 2 months of age for 
Cfh, Cfhr1, Cfhr2 (Cfhrb_4/2), Cfhr3, and Gm4788 (Cfhrc). 
Only Cfh and Cfhr2 were expressed in the RPE/choroid 
(Figure 3A). No gender-related difference in expression 
was observed (data not shown). The other related mRNAs 
were not detected. When qPCR was performed on the RPE/
choroid from the 129/Sv Cfh−/− mice [23] and their age and 
background-matched wild-type mice (129/Sv), a strong Cfh 
signal was detected in the wild-type (WT) mice and low 
expression in the knockout mice (Figure 3B). The general 
level of expression of Cfhr2 mRNA was low in the wild-type 
strains, C57BL/6 and 129/Sv, compared to Cfh mRNA. Inter-
estingly, we observed that Cfhr2 mRNA was significantly 
(p<0.05) upregulated in the Cfh knockout strain compared to 
the wild-type background strain (Figure 3C).
Localization of Cfh mRNA in RPE by ISH: To define the cell 
types in the posterior pole expressing Cfh transcripts, we 
performed in situ hybridization. The ISH results using the 
RNAscope 2.0 FFPE Assay are shown in Figure 4. In the 
RPE of the C57BL/6 and BALB/c mouse, the negative control 
Figure 1. Comparison of Cfh gene 
clusters between the human and the 
mouse. Note the difference in the 
number of related genes expressed, 
as well as in their organization on 
the chromosome between the two 
species.
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Figure 2. Comparison of the mouse 
and human complement factor 
H amino acid sequence and their 
SCR domains. Yellow denotes 
conserved amino acids, and green 
denotes homologous substitu-
tions. Abbreviations: SCR=short 
consensus repeats; mCfh=mouse 
Cfh; hCFH=human CFH.
Figure 3. qPCR data for Cfh and 
Cfhr2 from the mouse RPE/choroid. 
Quantitative real-time PCR (qPCR) 
results are shown for RPE/choroid 
samples (n=6) from C57BL/6 mice 
for Cfh and Cfhr2 (A). Results for 
129/Sv Cfh−/− mice along with their 
wild-type background strain (129/
Sv) are shown for Cfh (B) and Cfhr2 (C). Note that the Cfh message was still detected in the Cfh−/− mice, but at a low level. (*) denotes 
significant difference (p<0.05).
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Figure 4. In situ hybridization in the C57BL/6, BALB/c, 129/Sv, and 129/Sv Cfh−/− mouse eye. A C57BL/6 eye sectioned near the optic nerve 
with its negative control (A), RPE65 positive control (B), and Cfh probe (C) are shown. Similar in situ hybridization (ISH) results were 
observed in the BALB/c strain: negative control (D), RPE65 positive control (E), and Cfh probe (F). Note the robust Cfh mRNA signal in 
the RPE in both strains (Figure 4C,F). Negative and RPE65 positive controls and Cfh ISH results for a 129/Sv Cfh−/−mouse (H, J, L) and 
its background strain, 129/Sv (G, I, K) are shown. To visualize the Fast Red signal masked by the RPE pigment, the Fast Red fluorescence 
property was used to image the sections using a rhodamine filter for 129/Sv (M) and 129/Sv Cfh −/− (N). Note the greatly reduced signal in 
the RPE of the Cfh−/− eye compared to the background strain. RPE=retinal pigment epithelium. Scale bar=20 μm.
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probe DapB showed no signal (Figure 4A,D). The positive 
control, a probe for RPE65, showed a robust signal in the RPE 
as expected (Figure 4B,E). The Cfh message was expressed 
mainly in the RPE with negligible expression in the choroid 
(Figure 4C,F). In addition, no message was detected in the 
photoreceptors (data not shown).
The results for ISH in the Cfh knockout mice and their 
background strain 129/Sv are shown in Figure 4G–N. The 
Cfh knockout mice negative and positive controls (Figure 
4H,J, respectively) showed results similar to the background 
strain’s controls (Figure 4G,I, respectively). The background 
strain (129/Sv) produced results similar to the C57BL/6 mouse 
eye with the Cfh message observed in the RPE (Figure 4K). 
However, the Cfh message was still detected in the RPE of the 
knockout (Figure 4L), albeit the signal was greatly reduced. 
The intensity of the signal present can be better observed 
when the fluorescent property of Fast Red is utilized and the 
sections viewed using a rhodamine filter in the background 
strain and the Cfh−/− (Figure 4M,N, respectively).
Antibody specificity for mouse complement factor H: Western 
blot analysis confirmed that the two antibodies we used 
in our study identified mouse complement factor H (Cfh 
protein; Figure 5). The goat antibody recognized the purified 
mouse and human CFH protein (Figure 5A), while the rabbit 
antibody identified only the mouse Cfh protein (Figure 5B). 
Both antibodies recognized the Cfh protein in mouse serum 
as one primary band at approximately 155 kDa, which had 
the same molecular weight as the purified Cfh protein run as 
a positive control on the same gel. Western blots performed 
using knockout mouse serum demonstrated a loss of the Cfh 
protein band, which was clearly present in the C57BL/6 (B6) 
and wild-type background strain (129/Sv) serum, by both 
antibodies (Figure 5C). Note that both antibodies detected 
only one major protein band of 155 kDa in serum thus demon-
strating their specificity.
Complement factor H localization in the outer retina by 
immunohistochemistry: While ISH studies were performed 
to localize cells expressing mRNA, immunohistochemistry 
(IHC) was used to study Cfh protein distribution. The IHC 
results using both anti-Cfh antibodies in eye tissue from 
different mouse strains along with their negative controls 
are shown in Figure 6. The goat anti-Cfh antibody immu-
nolabeled photoreceptor outer segments (OS) of the BALB/c 
mouse eye, with occasional labeling extending into the photo-
receptor inner segments (IS), believed to be cone cells (Figure 
6C). When the goat anti-Cfh antibody was preabsorbed with 
a blocking peptide, and used alongside the stock antibody in 
Figure 5. Western blots using 
different anti-mouse Cf h anti-
bodies. Goat anti-mouse Cfh (A) 
and rabbit anti-mouse Cfh (B) anti-
bodies probed against increasing 
concentrations of human (0.05, 0.1, 
and 0.2 μg/ml in lanes 2–4, respec-
tively) and mouse (0.05, 0.1, and 0.2 
μg/ml in lanes 5–7, respectively) 
purified complement factor H, and 
increasing volumes of mouse serum 
(1, 2.5, 5.0, and 10 μl serum/lane, 
lanes 8–11, respectively, loaded 
40 μl total volume/lane). The goat 
anti-mouse Cfh antibody recog-
nized human and mouse Cfh, as 
well as Cfh in mouse serum (A), 
while the rabbit anti-mouse Cfh 
antibody recognized only mouse 
Cfh and Cfh in mouse serum (B). 
Nonspecific binding by secondary 
antibodies was tested by primary antibody deletion (Lane 12). Both antibodies used against serum (1 μl/lane) from 129/Sv Cfh−/− (KO) and 
their wild-type background strain 129/Sv (WT) recognized Cfh only in serum from the background strain (WT) and C57BL/6 (B6) serum 
ran as a control (C). Note that both antibodies recognized only one major band at approximately 155 kDa (red arrow), the approximate 
weight of Cfh.
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an IHC experiment, immunolabeling was completely absent 
with the preabsorbed antibody (Appendix 2).
A somewhat similar immunolabeling pattern was 
observed with the rabbit anti-Cfh antibody labeling the OS, 
but patchy labeling was also observed along the apical edge 
of the RPE (Figure 6D). In addition, this antibody labeled the 
choroid and occasionally the cytoplasm of some RPE cells.
Interestingly, both antibodies produced a different 
pattern in the 129/Sv background strain with immunolabeling 
occurring in the IS, compared to the OS in the BALB/c strain 
(Figure 6G,K). When the Cfh knockout was immunolabeled 
with either antibody, a signal in the IS was still observed, 
but the signal intensity was markedly reduced (Figure 6H,L).
Sagittal sections of a mouse eye immunolabeled with 
rhodopsin (green) and the goat anti-mouse Cfh antibodies 
(red) showed Cfh to be centrally localized as a band in the 
OS, with occasional Cfh labeling observed in what is believed 
to be cone cell IS (white arrowheads, Figure 7A). When a 
sagittal eye section was immunolabeled for blue and red/
green opsin antibodies (white), which label cone cells, and 
anti-Cfh antibody (red), a similar Cfh labeling pattern was 
observed (Figure 7B). However, polarized staining of Cfh and 
opsins was also observed. Thus, Cfh appears to be associated 
with rod and cone cells. To determine the location of Cfh in 
relation to the rod and cone photoreceptors, coronal sections 
from the C57BL/6 mice were used. This allowed us to acquire 
cross sections of rod and cone photoreceptors and to visualize 
the location of Cfh within both photoreceptor types. Coronal 
sections labeled with fluorescein conjugated WGA (labels 
matrix domains surrounding rod photoreceptors), and an anti-
Cfh antibody clearly show Cfh labeling (red) within the rod 
photoreceptor outer segments (Figure 7C,D). Note that not 
all rod outer segments (denoted by green rings) contain Cfh 
internally. This confirms what is seen in the sagittal sections, 
since Cfh is not located throughout the rod photoreceptors 
(green), only in the central region of rod OS (Figure 7A). 
When the coronal sections were labeled with fluorescein 
conjugated PNA (labels cone matrix domain-green) and an 
anti-Cfh antibody, Cfh (red) was clearly located inside the 
cone cells (Figure 7E,F).
Statistical analysis: For the qPCR experiments, RNA was 
isolated from the RPE/choroid from six animals (biologic 
replicates)/group. The qPCR analysis was performed for 
each biologic replicate, and each biologic replicate was run in 
Figure 6. Immunohistochemistry 
for Cfh protein expression in the 
BALB/c, 129/Sv, and 129/Sv Cfh−/− 
eye. A BALB/c male eye sectioned 
near the optic nerve labeled for Cfh 
using two anti-Cfh antibodies (C, 
D), along with its paired negative 
control (A, B). Goat anti-mouse Cfh 
antibody predominately labeled 
photoreceptor outer segments (OS) 
and what appear to be cone cell 
photoreceptor (arrow heads) inner 
segments (IS; C). The rabbit anti-
mouse Cfh antibody labeled OS, the 
apical edge of the retinal pigment 
epithelium (RPE) cells, and only 
lightly labeled the RPE cytoplasm 
(D). The 129/Sv background strain 
eyes and Cfh knockout (129/Sv Cfh 
−/−) eyes paired with their negative 
controls (E, F, I, J) immunolabeled 
with goat anti-mouse Cfh antibody 
(G, H) or rabbit anti-mouse Cfh 
antibody (K, L). Cfh labeling was 
observed in the Cfh knockout eyes (H, L) using both antibodies, but the signal was greatly reduced compared to the wild-type (WT) eyes 
(G, K). The residual presence of the signal could be due to cross-reactivity with Cfhr2 protein, since both antibodies recognize Cfh and 
Cfhr2 proteins. Scale bar=20 μm.
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triplicate. Therefore, the data for each biologic group were an 
average of eighteen individual replicate runs. Raw qPCR data 
were normalized to the geometric mean of the three reference 
genes Gapdh, B2M, and Hprt13. A pairwise t test for statis-
tical significance between each group was performed using 
a one-tailed unpaired Student’s t test. Statistically significant 
differences were defined as p<0.05.
DISCUSSION
Our results specifically address the expression and distribu-
tion of Cfh and Cfh-related genes in the mouse RPE/choroid. 
We did not detect Cfhr3, Cfhr1, or Gm4788 expression in the 
posterior pole of the mouse eye by qPCR. Similarly, Luo et al. 
found Cfh in the mouse retina and RPE/choroid but not Cfhr1 
using qPCR [12]. In addition, they verified the expression 
of Cfh but not Cfhr1 in vitro using primary cultured mouse 
RPE cells and a microglial cell line (BV2 cells) by qPCR [12]. 
In our experiments, we found clear evidence of strong Cfh 
expression and a low level of Cfhr2 expression.
In situ hybridization studies used an oligo probe designed 
to specifically detect only Cfh mRNA and not cross-react 
with Cfhr2. The ISH images of the outer retina (Figure 4) 
show that the RPE is the major source of Cfh mRNA in the 
outer retina. Cfh mRNA was absent in the outer nuclear layer 
and photoreceptors (data not shown). In situ hybridization 
studies in the Cfh knockout mouse confirmed the loss of most 
but not all expression of Cfh mRNA (Figure 4L,N). This low 
level signal in the knockout could possibly be the result of a 
read-through message of the knocked-out gene, and not due 
to cross-reactivity with other related family members, since 
the probe was designed specifically not to recognize Cfhr2.
In an attempt to get a clearer answer to the question of 
the tissue distribution of Cfh protein in the posterior pole, 
we developed a new freeze substitution fixation method 
to use with mouse-specific antibody preparations. Freeze 
substitution was primarily designed as a method for preparing 
samples for electron microscopy. Reviews of the use of this 
method in eye research can be found in the literature [24-26]. 
Figure 7. Cfh localization within 
rod and cone photoreceptors. 
A sagittal section from a male 
BALB/c mouse eye immunolabeled 
for rhodopsin (green), Cfh (red), 
and a 4’,6-diamidino-2-phenylin-
dole (DAPI) nuclear stain (blue) 
showed only a localized band of 
Cfh in the central region of the OS 
(white arrow), but not throughout 
the OS. In addition, occasional 
Cfh labeling of cells believed to be 
cone cell IS was observed (white 
arrowheads; A). A sagittal section 
from a male BALB/c mouse eye 
immunolabeled for blue and red/
green opsins (white), Cfh (red), and 
a DAPI nuclear stain (blue) showed 
a similar band of Cfh in the central 
region of the OS (green arrow; B). 
Cone cells labeled with the opsin 
antibodies (green arrowheads) 
exhibit a polarized distribution of 
blue and red/green opsins (white) 
and Cfh (red). A coronal section 
from a male C57BL/6 eye double labeled with fluorescein conjugated WGA (green), which labels the matrix domains surrounding rod 
photoreceptors, and Cfh (red) showing Cfh within rod photoreceptor OS (C). The delineated area of interest is magnified and shown on the 
right. Cfh is clearly localized within the rods (arrows; D). A coronal section from a male C57BL/6 eye labeled with fluorescein conjugated 
PNA (green), which binds cone matrix domains, and Cfh (red) showing Cfh is clearly localized within the cone cells (arrows; E). The 
delineated area of interest is magnified and shown on the right (F). IS=photoreceptor inner segments; OS=outer segments; RPE=retinal 
pigment epithelium; WGA=wheat germ agglutinin; PNA=peanut agglutinin. Scale bar=20 μm.
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In addition to this primary use, however, several newer reports 
have illustrated the use of freeze substitution for immunohis-
tochemistry at the light microscopy level [27,28]. We chose 
this method based on its superior ability to preserve tissue 
morphology and antigenicity for the antibodies we used. 
In the mouse, alcohols and acetone have been explored for 
flash-freezing techniques with whole eyes, and an extension 
of these methods has been used for in situ cryopreservation in 
the living mouse [27,28]. We explored methanol/acetic acid, 
acetone/2% formaldehyde, and acetone/2% paraformaldehyde 
for freeze substitution (data not shown). The best result in 
terms of morphology and antigen preservation for immuno-
histochemistry was methanol containing 3% acetic acid as 
reported by Yoon and FitzGerald [29].
On the protein level, there are several reports of Cfh 
localization in the eye, with varying results. Kim et al., using 
cell culture and western blots, and Quidel’s goat anti-human 
CFH antiserum showed that bovine and human RPE cells 
make and secrete Cfh and that interferon-gamma (IFN-
gamma) increases Cfh production. Only weak labeling of Cfh 
was observed in the RPE, unless stimulated with IFN-gamma 
[30]. Mandal and Ayyagari also used Quidel’s goat anti-human 
CFH antiserum on the mouse eye and observed labeling in 
the mouse RPE, IS, outer plexiform layer (OPL), inner plexi-
form layer (IPL), ganglion cell layer (GCL), and limiting 
membranes [13]. We attempted to purify the Quidel goat 
anti-human CFH antiserum using immunoaffinity columns, 
but after affinity purification, mouse Cfh protein immuno-
labeling in the mouse tissue was significantly reduced (data 
not shown). Chen et al. used Abcam’s sheep anti-human CFH 
antibody, which labeled mouse RPE, Bruch’s membrane, and 
a choroidal vessel [16]. Lyzogubov et al. also used an Abcam 
sheep anti-human CFH antibody that labeled only mouse RPE 
[17]. Von Leithner et al. used a Calbiochem goat anti-human 
CFH antiserum and found labeling only in Bruch’s membrane 
of the mouse eye [14]. Liu et al. reported Cfh protein in the 
mouse photoreceptor sensory cilium complex [15]. Addition-
ally, we observed strain variation in Cfh localization within 
photoreceptors. The only group that found results similar to 
ours is Amadi-Obi et al., who used a goat anti-mouse Cfh 
antibody. They found labeling in the mouse OS, not the RPE 
[31]. Our immunohistochemistry results localize the Cfh 
protein in photoreceptors not in the RPE. Given the antigenic 
differences between mouse and human complement proteins, 
antibodies specific for a particular species proteins should be 
used and cross-reactivity studies performed with western or 
dot blot analysis.
We purposely chose two antibodies that were produced 
using mouse Cfh antigens as the immunogen. The goat 
anti-mouse Cfh antibody was raised against a peptide (amino 
acids 250–300) mapping within an internal region of Cfh of 
mouse origin. The rabbit anti-mouse Cfh antibody was raised 
against amino acids 61–360 mapping within an internal region 
of factor H of mouse origin. In addition, the antibodies were 
affinity purified to help reduce non-specific binding. Each 
antibody’s immunogen sequence was run through a BLAST 
search algorithm against the mouse protein database at the 
NCBI to test for cross-reactivity with other mouse proteins 
(data not shown). The BLAST results for both antibodies 
showed significant homology only with the Cfh and Cfhr2 
(Cfhrb) proteins.
Our western blots are somewhat different from those 
published by other groups [11,32]. Most of these groups used 
sodium dodecyl sulfate (SDS) gels under oxidizing condi-
tions. Our gels were run with reducing agent (beta mercapto-
ethanol), to reduce any disulfide bonds, and the blots clearly 
identify only one 155 kDa band equivalent to a Cfh protein 
monomer (Figure 5). The possibilities for additional bands 
on western blots from other authors may be due to cross-
reactivity to other CFH-related proteins, or Cfh dimers [32].
When the Cfh knockout was immunolabeled with either 
antibody, a signal in the IS was still observed, but the signal 
intensity was markedly reduced (Figure 6H,L). Since both 
antibodies were produced with immunogens that share 
90–95% homology with Cfhr2, it is expected that each 
antibody would recognize Cfhr2 protein. In addition, we 
observed mildly increased expression of Cfhr2 mRNA in the 
knockout mice (Figure 3C), which could have led to elevated 
Cfhr2 protein expression in the knockout mice.
The orientation of whole fixed eyes allows for the orien-
tation of individual paraffin sections, among other benefits. 
Most of our images present a sagittal section near or through 
the optic disc. At first, we concluded that the distribution of 
Cfh immunolabeling was in the inferior portion of the sagittal 
sections. Several papers in the literature have discussed polar-
ized distribution of gene expression and/or protein distribu-
tion between the superior and inferior regions of the mouse 
retina [13,33-35]. However, our work did not contain adequate 
positive controls to verify this finding for Cfh. Additionally, 
some of the authors cited used flat mounts with an orientation 
to give a complete view of the labeled regions.
Taken together, our results suggest that the RPE is the 
primary source for producing Cfh in the RPE/choroid and that 
the resulting protein is likely secreted into the inner photo-
receptor matrix space. We have not addressed the variability 
in the location of Cfh within the inner photoreceptor matrix. 
We found evidence for Cfh labeling inside rod outer segments 
and inside cone cell inner segments. This topic requires more 
Molecular Vision 2015; 21:110-123 <http://www.molvis.org/molvis/v21/110> © 2015 Molecular Vision 
121
examination with better tools to sort out the effects of Cfh 
transport and the possibility of its variable localization being 
attributed to a diurnal rhythm.
APPENDIX 1. 
Mouse and human CFH genes and corresponding protein 
names in the literature. To access the data, click or select the 
words “Appendix 1.”
APPENDIX 2.
To access the data, click or select the words “Appendix 2.” 
Immunohistochemistry of a male BALB/c eye labeled using 
goat anti-Cfh antibody (A) and goat anti-Cfh antibody 
pre-absorbed with blocking peptide (B).  Pre-absorbing the 
antibody with the blocking peptide completely eliminated 
the signal.  Scale bar equals 20 microns.  Abbreviations: 
inner nuclear layer (INL), outer nuclear layer (ONL), inner 
segments (IS), outer segments (OS), retinal pigment epithe-
lium (RPE).
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